P468 Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []